SYLENTIS Phase II: Dose finding clinical trial with SYL040012 to evaluate the tolerability and effect on intraocular pressure in subjects with ocular hypertension or open-angle glaucoma
Laufzeit: 01.01.2011 - 31.12.2013
Kurzfassung
Dose finding clinical trial with SYL040012 to evaluate the tolerability and effect on intraocular pressure in subjects with ocular hypertension or open-angle glaucoma
